fda declaratory order semaglutide shortage resolved february 21 2025 GLP-1 Drugs: Removes from the Drug List Federal judge upholds FDA's removal

In January, Novo Nordisk maker of both semaglutide brands could effectively lose its market exclusivity in Canada, likely opening the door to generic versions, CBC News previously reported

NAC discussion gets really interesting

Know your current weight, BMI, blood glucose levels, and medication list before you reach out to a trial site

Practical Implications If you are taking semaglutide for diabetes or weight loss, consider discussing magnesium supplementation with your healthcare provider

Continuous albumin-bound circulation supports protocols requiring sustained receptor engagement without acute concentration spikes